For the next 12 months, you will be under the influence of Number 8, which is ruled by Shani Dev. Let us explore what the coming year has in store for you.

Is SLS a good stock to buy? We came across a bullish thesis on SELLAS Life Sciences Group, Inc. on BioEquity Watch’s Substack ...

George Forster's short-but-restless life found him at the center of revolutions in science, art and politics during the tumult of late 18th-century Europe.

Fine-scale exogenous attention within the foveola selectively enhances contrast gain at low-to-mid spatial frequencies while increasing response gain across a broad spatial frequency range.

The bond money would be split to fund an immunology and immunotherapy research institute affiliated with the University of ...

Acquisition adds YUPELRI ® (revefenacin), the first and only approved nebulized long-acting muscarinic antagonist (LAMA) for the maintenance treatment of COPD to Zymeworks' portfolio Acquisition of ...

Investor interest has focused on companies nearing key milestones, signing major partnerships, or improving their business ...

Then advances in ancient DNA revealed a story of this child, buried over ten thousand years ago. It was a story far greater than anyone could have guessed. The child known to archaeologists as the ...

Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor ...

The transaction brings together PharmaSource, CDMO Live Europe, CDMO Live Americas and External Manufacturing Leaders with LSC’s existing platforms.

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

A new bill in California is set to make it more clear. But if you don’t live in California, here’s what you need to know.